The Anatolian Journal of Cardiology

Renal and metabolic effects of valsartan

1.

Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, İstanbul Bilim University; İstanbul-Turkey

Anatol J Cardiol 2014; 14: Supplement S14-S19
DOI: 10.5152/akd.2014.00003
Read: 158 Downloads: 55 Published: 01 July 2021

It is known that the drugs which suppress the renin-angiotensin-aldosterone system can prevent target organ damage, independent of their blood pressure lowering effects. Besides, it has been reported that this group of drugs has positive metabolic effects. There are many studies showing that valsartan, being an angiotensin receptor blocker and widely used in hypertension treatment, has cardioprotective and renoprotective effects in high risk patients. It has been seen in these studies that, valsartan treatment has a decreasing effect on proteinuria, independent of its blood pressure lowering effects in the patients having either diabetic and non-diabetic nephropathy. In this review, the studies investigating the renal effects of valsartan will be mentioned. Additionally, the studies about the metabolic effects of valsartan will be reported.

Files
ISSN 2149-2263 EISSN 2149-2271